- Home
- AXSM vs ITRI Comparison
AXSM vs ITRI Comparison
Compare AXSM & ITRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ITRI
- Stock Information
- Founded
- AXSM 2012
- ITRI 1977
- Country
- AXSM United States
- ITRI United States
- Employees
- AXSM N/A
- ITRI N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ITRI Electrical Products
- Sector
- AXSM Health Care
- ITRI Industrials
- Exchange
- AXSM Nasdaq
- ITRI Nasdaq
- Market Cap
- AXSM 5.1B
- ITRI 5.6B
- IPO Year
- AXSM 2015
- ITRI 1993
- Fundamental
- Price
- AXSM $100.69
- ITRI $128.08
- Analyst Decision
- AXSM Strong Buy
- ITRI Strong Buy
- Analyst Count
- AXSM 16
- ITRI 10
- Target Price
- AXSM $170.50
- ITRI $126.80
- AVG Volume (30 Days)
- AXSM 627.1K
- ITRI 521.4K
- Earning Date
- AXSM 08-04-2025
- ITRI 07-31-2025
- Dividend Yield
- AXSM N/A
- ITRI N/A
- EPS Growth
- AXSM N/A
- ITRI 57.53
- EPS
- AXSM N/A
- ITRI 5.48
- Revenue
- AXSM $432,157,000.00
- ITRI $2,444,546,000.00
- Revenue This Year
- AXSM $62.84
- ITRI $2.96
- Revenue Next Year
- AXSM $60.02
- ITRI $5.89
- P/E Ratio
- AXSM N/A
- ITRI $23.29
- Revenue Growth
- AXSM 72.16
- ITRI 7.10
- 52 Week Low
- AXSM $72.02
- ITRI $90.11
- 52 Week High
- AXSM $139.13
- ITRI $129.83
- Technical
- Relative Strength Index (RSI)
- AXSM 37.30
- ITRI 76.28
- Support Level
- AXSM $99.39
- ITRI $121.00
- Resistance Level
- AXSM $112.98
- ITRI $125.40
- Average True Range (ATR)
- AXSM 3.33
- ITRI 2.27
- MACD
- AXSM -0.76
- ITRI 0.43
- Stochastic Oscillator
- AXSM 9.35
- ITRI 92.38
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ITRI Itron Inc.
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.